IllinoisSB2921104th General Assembly (2025–2026)SenateWALLET

INS-EYE MEDICATION COVERAGE

Sponsored By: Laura Fine (Democratic)

Signed by Governor

Summary

Amends the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Illinois Public Aid Code to require coverage for eye medication under the provisions of those Acts pursuant to the Topical Eye Medication Prescription Act.

assignmentsinsuranceprescription drug affordability & accessibility

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

5 provisions identified: 4 benefits, 0 costs, 1 mixed.

Employer health plans must cover eye meds

If you have employer‑sponsored health insurance, your plan must cover post‑mastectomy care and topical eye medications. Plans must also follow other listed Illinois insurance protections. The Department of Insurance enforces these rules. This applies beginning January 1, 2028.

Medicaid covers post-mastectomy and eye medicine

Medicaid covers post‑mastectomy care and topical eye medications. The program must pay hospitals and doctors at least the Medicare rate for that care. Medicaid must also follow network adequacy and other listed protections. These rules apply starting January 1, 2028.

More coverage in state and local plans

The State Employee Group Insurance Program and self‑insured counties and cities must cover post‑mastectomy care and topical eye medications. They also must follow listed Illinois insurance protections. The Department of Insurance enforces parts on provider coverage, and Central Management Services enforces the rest. These rules take effect January 1, 2028.

More required benefits in HMOs and limited plans

HMOs, limited health service plans, and health services plan corporations must cover topical eye medications and follow listed Illinois insurance protections. Limited plans are not forced to cover services outside their defined scope. Some sections do not apply to plans under contract with the Department of Healthcare and Family Services. HMOs with at least 30% of enrollees living in Illinois are treated as Illinois 'domestic' for many insurance rules, strengthening state oversight. These changes take effect January 1, 2028.

Caps on HMO group refunds and surcharges

Your HMO group contract can include refunds or extra premiums based on your group’s claims. Any refund or extra charge is capped at 20% for the contract period, and contracts must last at least one year. These rules do not apply to small employer groups or Medicare supplement policies. HMOs must disclose that these adjustments are possible and explain the math on request. The rules start January 1, 2028.

Sponsors & Cosponsors

Sponsor

  • Laura Fine

    Democratic • Senate

Cosponsors

  • Cristina Castro

    Democratic • Senate

  • Graciela Guzmán

    Democratic • Senate

  • Jawaharial Williams

    Democratic • House

  • Mary Edly-Allen

    Democratic • Senate

  • Mattie Hunter

    Democratic • Senate

  • Mike Simmons

    Democratic • Senate

  • Nicolle Grasse

    Democratic • House

  • Rachel Ventura

    Democratic • Senate

  • Sara Feigenholtz

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 184 • No: 1

House vote • 5/21/2026

Third Reading - Short Debate - Passed

Yes: 110 • No: 0

House vote • 5/6/2026

Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee;

Yes: 13 • No: 0

Senate vote • 4/14/2026

Third Reading - Passed;

Yes: 52 • No: 1

Senate vote • 3/4/2026

Do Pass as Amended Insurance;

Yes: 9 • No: 0

Actions Timeline

  1. Public Act . . . . . . . . . 104-0649

    7/24/2026Senate
  2. Effective Date January 1, 2028

    7/24/2026Senate
  3. Governor Approved

    7/24/2026Senate
  4. Added as Co-Sponsor Sen. Mary Edly-Allen

    6/30/2026Senate
  5. Sent to the Governor

    6/18/2026Senate
  6. Added Alternate Co-Sponsor Rep. Jawaharial Williams

    5/21/2026House
  7. Passed Both Houses

    5/21/2026Senate
  8. Third Reading - Short Debate - Passed 110-000-000

    5/21/2026House
  9. Placed on Calendar Order of 3rd Reading - Short Debate

    5/19/2026House
  10. Second Reading - Short Debate

    5/19/2026House
  11. Placed on Calendar 2nd Reading - Short Debate

    5/7/2026House
  12. Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000

    5/6/2026House
  13. Alternate Chief Sponsor Changed to Rep. Nicolle Grasse

    4/29/2026House
  14. Assigned to Prescription Drug Affordability & Accessibility Committee

    4/27/2026House
  15. Added as Co-Sponsor Sen. Rachel Ventura

    4/15/2026Senate
  16. Referred to Rules Committee

    4/14/2026House
  17. First Reading

    4/14/2026House
  18. Chief House Sponsor Rep. Bob Morgan

    4/14/2026House
  19. Arrived in House

    4/14/2026House
  20. Third Reading - Passed; 052-001-000

    4/14/2026Senate
  21. Added as Co-Sponsor Sen. Sara Feigenholtz

    4/13/2026Senate
  22. Added as Co-Sponsor Sen. Graciela Guzmán

    3/27/2026Senate
  23. Added as Co-Sponsor Sen. Mike Simmons

    3/26/2026Senate
  24. Added as Co-Sponsor Sen. Mattie Hunter

    3/26/2026Senate
  25. Placed on Calendar Order of 3rd Reading March 26, 2026

    3/25/2026Senate

Bill Text

Related Bills

Back to State Legislation